CD34 and cancer: Yet despite this significant limitation, taken together, the data demonstrate that human immune lineages, including myeloid cells, can develop from MBP-CD34 cells from adult HNSCC cancer patients and allow for engraftment and chimerism of immunodeficient mice with major immune compartments represented.